Safety of Aspirin for Cardiovascular Disease in China: A Systematic Review and Meta-analysis

被引：0
|
作者：
Zhuo, Lin [1 ]
Cheng, Yinchu [1 ]
Zhang, Yang [1 ]
机构：
[1] Peking Univ, Hlth Sci Ctr, Dept Epidemiol & Biostat, Beijing 100871, Peoples R China
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2015年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
562
引用
收藏
页码：321 / 321
页数：1
相关论文
共 50 条
  • [1] Aspirin in the primary prevention of cardiovascular disease on diabetic patients: Systematic review and meta-analysis
    Caldeira, Daniel
    Alves, Mariana
    David, Claudio
    Costa, Joao
    Ferreira, Joaquim J.
    Pinto, Fausto J.
    [J]. PRIMARY CARE DIABETES, 2020, 14 (03) : 213 - 221
  • [2] Cardiovascular Safety of Evolocumab: a Systematic Review and Meta-Analysis
    Krittanawong, Chayakrit
    Kitai, Takeshi
    Zhang, HongJu
    Sun, Tao
    [J]. CARDIOVASCULAR DRUGS AND THERAPY, 2016, 30 (06) : 645 - 646
  • [3] Cardiovascular Safety of Evolocumab: a Systematic Review and Meta-Analysis
    Chayakrit Krittanawong
    Takeshi Kitai
    HongJu Zhang
    Tao Sun
    [J]. Cardiovascular Drugs and Therapy, 2016, 30 : 645 - 646
  • [4] Systematic Review, Meta-analysis, and Network Meta-analysis of the Cardiovascular Safety of Macrolides
    Gorelik, Einat
    Masarwa, Reem
    Perlman, Amichai
    Rotshild, Victoria
    Muszkat, Mordechai
    Matok, Ilan
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (06)
  • [5] Aspirin for the primary prevention of cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis
    Pallikadavath, Susil
    Ashton, Leah
    Brunskill, Nigel J.
    Burton, James O.
    Gray, Laura J.
    Major, Rupert W.
    [J]. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2022, 28 (17) : 1953 - 1960
  • [6] Aspirin "resistance" and risk of cardiovascular morbidity: systematic review and meta-analysis
    Krasopoulos, George
    Brister, Stephanie J.
    Beattie, W. Scott
    Buchanan, Michael R.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2008, 336 (7637): : 195 - 198H
  • [7] Is there a cardiovascular protective effect of aspirin in chronic kidney disease patients? A systematic review and meta-analysis
    Qu, Bo
    He, Yuhua
    Wu, Lihua
    Lu, Hongmei
    Wu, Haili
    Li, Mingquan
    [J]. INTERNATIONAL UROLOGY AND NEPHROLOGY, 2020, 52 (02) : 315 - 324
  • [8] Cardiovascular Protection of Aspirin in Chronic Kidney Disease Patients: An Updated Systematic Review and Meta-Analysis
    Chen, Ting
    Deng, Yunlei
    Gong, Rong
    [J]. CURRENT VASCULAR PHARMACOLOGY, 2024, 22 (04) : 287 - 296
  • [9] Is there a cardiovascular protective effect of aspirin in chronic kidney disease patients? A systematic review and meta-analysis
    Bo Qu
    Yuhua He
    Lihua Wu
    Hongmei Lu
    Haili Wu
    Mingquan Li
    [J]. International Urology and Nephrology, 2020, 52 : 315 - 324
  • [10] Safety and efficacy of aspirin and indobufen in the treatment of coronary heart disease: a systematic review and meta-analysis
    Zhang, Xiaochen
    Yan, Qiaoyan
    Jiang, Jiao
    Luo, Hua
    Ren, Yu
    [J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2024, 11
12345